Carolyn E. Behrendt

2.0k total citations
44 papers, 1.5k citations indexed

About

Carolyn E. Behrendt is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, Carolyn E. Behrendt has authored 44 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 13 papers in Pulmonary and Respiratory Medicine and 7 papers in Epidemiology. Recurrent topics in Carolyn E. Behrendt's work include HER2/EGFR in Cancer Research (4 papers), Cancer survivorship and care (4 papers) and BRCA gene mutations in cancer (3 papers). Carolyn E. Behrendt is often cited by papers focused on HER2/EGFR in Cancer Research (4 papers), Cancer survivorship and care (4 papers) and BRCA gene mutations in cancer (3 papers). Carolyn E. Behrendt collaborates with scholars based in United States, Germany and Peru. Carolyn E. Behrendt's co-authors include Michael D. Decker, Daniel Burch, Brian L. Kotzin, Nancy S. Ricalton, J.E.F. Fitzgerald, Anja Meyer, Henry J. Kaplan, Thomas Meyer, T. Schultewolter and Eggert Stockfleth and has published in prestigious journals such as The Journal of Experimental Medicine, Journal of Clinical Oncology and The Journal of Immunology.

In The Last Decade

Carolyn E. Behrendt

42 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Carolyn E. Behrendt United States 19 483 397 272 235 166 44 1.5k
Martin Wetzke Germany 21 479 1.0× 401 1.0× 648 2.4× 175 0.7× 75 0.5× 79 1.8k
Asha Moudgil United States 23 294 0.6× 279 0.7× 215 0.8× 209 0.9× 192 1.2× 111 2.0k
Gabrielle Morgan United States 22 1.0k 2.1× 220 0.6× 353 1.3× 53 0.2× 98 0.6× 64 2.4k
Claudia Biasini Italy 13 340 0.7× 241 0.6× 282 1.0× 421 1.8× 155 0.9× 24 1.3k
Corianne A.J.M. de Borgie Netherlands 16 376 0.8× 111 0.3× 430 1.6× 75 0.3× 188 1.1× 32 1.5k
Andrea Baran United States 17 337 0.7× 125 0.3× 172 0.6× 174 0.7× 90 0.5× 81 1.1k
Zuber D. Mulla United States 23 208 0.4× 179 0.5× 77 0.3× 177 0.8× 390 2.3× 105 1.6k
Joanna Harp United States 13 464 1.0× 183 0.5× 298 1.1× 267 1.1× 149 0.9× 32 2.5k
Hui‐Kim Yap Singapore 26 294 0.6× 266 0.7× 456 1.7× 62 0.3× 158 1.0× 141 2.3k
P. Mercié France 31 619 1.3× 123 0.3× 175 0.6× 195 0.8× 151 0.9× 122 2.9k

Countries citing papers authored by Carolyn E. Behrendt

Since Specialization
Citations

This map shows the geographic impact of Carolyn E. Behrendt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carolyn E. Behrendt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carolyn E. Behrendt more than expected).

Fields of papers citing papers by Carolyn E. Behrendt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carolyn E. Behrendt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carolyn E. Behrendt. The network helps show where Carolyn E. Behrendt may publish in the future.

Co-authorship network of co-authors of Carolyn E. Behrendt

This figure shows the co-authorship network connecting the top 25 collaborators of Carolyn E. Behrendt. A scholar is included among the top collaborators of Carolyn E. Behrendt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carolyn E. Behrendt. Carolyn E. Behrendt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Behrendt, Carolyn E., et al.. (2025). PD1+ innate lymphoid cells 3 predict JAK-dependent inflammation in rheumatoid arthritis. Journal of Autoimmunity. 154. 103424–103424.
2.
Rainone, Michael, Carolyn E. Behrendt, Saro Kasparian, et al.. (2023). HER2-targeted antibody–drug conjugates for breast cancer: ancestry and dose adjustment for thrombocytopenia. Breast Cancer. 30(5). 796–801. 3 indexed citations
3.
Behrendt, Carolyn E., Susan E. Yost, Niki Patel, et al.. (2023). Predicting Hyperglycemia Among Patients Receiving Alpelisib Plus Fulvestrant for Metastatic Breast Cancer. The Oncologist. 28(7). e488–e492. 5 indexed citations
4.
Reckamp, Karen L., Carolyn E. Behrendt, Thomas P. Slavin, et al.. (2021). Germline mutations and age at onset of lung adenocarcinoma. Cancer. 127(15). 2801–2806. 18 indexed citations
5.
Woo, Yanghee, Carolyn E. Behrendt, Annie Yang, et al.. (2021). Tumor Epigenetic Signature and Survival in Resected Gastric Cancer Patients. Journal of the American College of Surgeons. 232(4). 483–491e1. 9 indexed citations
6.
Schmolze, Daniel, Carolyn E. Behrendt, Peter P. Lee, & Sophia K. Apple. (2019). The Prognostic Value of PD-L1 Expression in Triple-Negative Breast Cancer: A Cohort Study and Systematic Literature Review. 2(1). 1–8. 1 indexed citations
7.
Behrendt, Carolyn E., Candace M. Cosgrove, Norman J. Johnson, & Sean F. Altekruse. (2019). Are associations between psychosocial stressors and incident lung cancer attributable to smoking?. PLoS ONE. 14(6). e0218439–e0218439.
8.
Mortimer, Joanne, Sarah Waliany, Christina M. Dieli‐Conwright, et al.. (2017). Objective physical and mental markers of self‐reported fatigue in women undergoing (neo)adjuvant chemotherapy for early‐stage breast cancer. Cancer. 123(10). 1810–1816. 13 indexed citations
9.
Behrendt, Carolyn E., Arti Hurria, Lusine Tumyan, Joyce C. Niland, & Joanne Mortimer. (2014). Socioeconomic and Clinical Factors Are Key To Uncovering Disparity in Accrual Onto Therapeutic Trials for Breast Cancer. Journal of the National Comprehensive Cancer Network. 12(11). 1579–1585. 7 indexed citations
10.
Behrendt, Carolyn E., Lusine Tumyan, Lalitkumar K. Vora, et al.. (2014). Evaluation of expert criteria for preoperative magnetic resonance imaging of newly diagnosed breast cancer. The Breast. 23(4). 341–345. 7 indexed citations
11.
Behrendt, Carolyn E., Ryotaro Nakamura, Stephen J. Forman, & John A. Zaia. (2013). Donor killer immunoglobulin-like receptor genes and reactivation of cytomegalovirus after HLA-matched hematopoietic stem-cell transplantation: HLA-C allotype is an essential cofactor. Frontiers in Immunology. 4. 36–36. 10 indexed citations
12.
Behrendt, Carolyn E., et al.. (2013). Incidence of Inflammatory Breast Cancer in Women, 1992–2009, United States. Annals of Surgical Oncology. 21(4). 1267–1270. 27 indexed citations
13.
Behrendt, Carolyn E., et al.. (2012). Severe Hyperglycemia Immediately After Allogeneic Hematopoietic Stem-Cell Transplantation is Predictive of Acute Graft-Versus-Host Disease. Inflammation. 36(1). 177–185. 29 indexed citations
14.
Behrendt, Carolyn E., et al.. (2012). Predicting Acute and Persistent Neuropathy Associated With Oxaliplatin. American Journal of Clinical Oncology. 36(4). 331–337. 61 indexed citations
16.
Behrendt, Carolyn E., et al.. (2005). Cerebral Ischemic Events in Patients with Advanced Lung or Prostate Cancer. Neuroepidemiology. 24(4). 230–236. 4 indexed citations
17.
Behrendt, Carolyn E.. (2004). Visual acuity and its decrease in classic neovascular age-related macular degeneration. Ophthalmic Epidemiology. 11(5). 359–367. 5 indexed citations
18.
Bradley, John S., Carolyn E. Behrendt, Antonio Arrieta, et al.. (2001). Convalescent phase outpatient parenteral antiinfective therapy for children with complicated appendicitis. The Pediatric Infectious Disease Journal. 20(1). 19–24. 22 indexed citations
19.
Behrendt, Carolyn E.. (2000). Acute Respiratory Failure in the United States. CHEST Journal. 118(4). 1100–1105. 177 indexed citations
20.
Donahue, John P., Nancy S. Ricalton, Carolyn E. Behrendt, et al.. (1994). Genetic analysis of low V beta 3 expression in humans.. The Journal of Experimental Medicine. 179(5). 1701–1706. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026